Clostridium Botulinum Type C Bacterin-Toxoid.

CFR · 2024-01-01 · US · Title 9

Clostridium Botulinum Type C Bacterin-Toxoid shall be produced from a culture of (a) (b) (c) (1) Each of the vaccinates shall be injected subcutaneously with the dose recommended on the label for mink. Twenty-one to twenty-eight days post-injection, the vaccinates and the controls shall be challenged intraperitoneally with botulinum Type C toxin which has been titrated in mice to provide for a 10 (2) The vaccinates and controls shall be observed for 7 days post-challenge and signs of botulism and deaths noted. For a valid test, the controls shall die of botulism. If the test is valid and 80 percent of the vaccinates do not remain free of botulism, the serial is unsatisfactory.

official document · source cfr-2024 · id 9:§ 113.110